Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Santhera Pharmaceuticals Holding AG. (9/9/14). "Press Release: Santhera Reports First Half 2014 Financial Results and Positive Developments in All Strategic Program". Liestal.

Organisation Organisation Santhera Pharmaceuticals Holding AG (SIX: SANN)
  Group Santhera (Group)
Products Product Raxone®
  Product 2 Catena®
  Index term 2 Santhera–SEVERAL: investment, 201407–201408 sale CHF13.4m of 200k treasury common shares at CHF66.85/share
Person Person Meier, Thomas (Santhera 201303 CEO before CSO)
     


   
Record changed: 2017-04-02

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Santhera (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px




» top